Search results

Radiocarbon dating capabilities at the Centre for Accelerator Science have provided evidence of a 17,300-year old painting of a kangaroo from the Kimberley region.

ANSTO will make an application to the independent nuclear regulator, ARPANSA, to vary its license for its Interim Waste Store. The original operating license was approved in 2015, enabling the facility to hold what is called a TN-81 cask of intermediate-level radioactive waste that was safely repatriated from France in 2015.

Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.

The outstanding contribution of individuals and teams was recognised in the 2026 ANSTO Awards, which spotlights the achievements of staff who excel in diverse areas of the organisation. 

The Australian Centre for Neutron Scattering and National Deuteration Facility have announced the first recipients of the Neutron and Deuteration Impact Awards. 

Rare earth elements will be a key area of focus for the Australian Nuclear Science and Technology Organisation’s Minerals unit as it welcomes a $13.9 million funding allocation under the Australian Critical Minerals Research and Development Hub

ANSTO plays a leading role in measuring and characterising fine particles from a range of locations around Australia and internationally.

A large team of ANSTO scientists in collaboration with University of Wollongong researchers has developed a new hybrid technique that enhances the effectiveness of a cutting-edge form of radiation therapy for advanced cancer.

A collaboration of scientists from RMIT, ANSTO and the CSIRO has published pioneering research that brings new insights into intrinsically disordered proteins and protein regions (IDPs)/ (IDRs) and how they behave under various physiological processes.

ANSTO is responsible for the Little Forest Legacy Site (LFLS) located within the ANSTO Buffer Zone boundary. This site, formerly known as the Little Forest Burial Ground (LFBG), was used by the Australian Atomic Energy Commission (AAEC) during the 1960’s to dispose of waste containing low levels of radioactivity and beryllium oxide (non-radioactive) in a series of shallow trenches. There has been regular monitoring of the site since 1966 and the results have been reported in ANSTO’s environmental monitoring reports.

Research explores how structure contributes to function in food

A specialist in particle therapy treatment planning from the Mayo Clinic in the US, Professor Chris Beltran, recently visited ANSTO for an exchange for information.

Explore ANSTO's range of publications and reports available for the public.

A new nuclear medicine waste processing facility that showcases ANSTO Synroc technology is under construction.

Environmental scientist with a passion for fieldwork and a lifelong commitment to scientific excellence

Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.

ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.

Imaging protocol assesses molecular mechanism of work in the treatment of deadly childhood cancer neuroblastoma.

ANSTO researchers are investigating nuclear propulsion systems for applications on the sea and in space.